X
Record #31553

First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset

Publisher
Wiley
Original paper date
Sep 14, 2020
Original DOI
10.1111/cas.14647
Institution
Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan · Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan · Division of Thoracic Oncology, Shizuoka Cancer Center, Shuntougun, Japan · Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan · Department of Medical Oncology, National Hospital Organization Yamaguchi Ube Medical Center, Ube, Japan · Department of Thoracic Oncology, Kansai Medical University, Osaka, Japan · Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan · Department of Thoracic Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan · Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan · Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan · Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan · Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan · Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan · Internal Medicine III, Wakayama Medical University, Wakayama, Japan · Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan · Department of Respiratory Medicine, Respiratory Center, Totanomon Hospital, Tokyo, Japan · Division of Integrated Oncology, Institute of Biomedical Research and Innovation Hospital, Kobe, Japan · Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan · Department of Thoracic Oncology, Aichi Cancer Center, Aichi, Japan · Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan · Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan · Department of Surgery, Tokyo Medical University, Tokyo, Japan · MSD K.K., Tokyo, Japan · Merck & Co., Inc., Kenilworth, NJ, USA · Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan
Open access
No
Article type
Clinical Study
Broad categories
(HSC) Medicine - Oncology(HSC) Medicine - Pharmacology(HSC) Medicine - Pulmonology(HSC) Medicine - Rehabilitation/Therapy
Citation lifecycle

How this paper is being cited

Pre-retraction
7
Same day
0
Post-retraction
17
% post-retraction
70.8%
~7.7 citations/yr before retraction · ~3.3 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse